Proinflammatory CD14 +CD16 + monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia

Inflammation

Volumn 35, Issue 1, 2012, Pages 388-396

  Yang, Mengxue ^a,b   Gan, Hua ^a   Shen, Qing ^a   Tang, Weixue ^a   Du, Xiaogang ^a   Chen, Danyan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

CD14 +CD16 + monocytes; Diabetic nephropathy; Microinflammation; Toll like receptor; Type 2 diabetes mellitus; Uremia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; I KAPPA B; INTERLEUKIN 6; STAT5 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ADULT; AGED; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPERNATANT; TURBIDIMETRY; UPREGULATION; UREMIA; WESTERN BLOTTING;

ANTIGENS, CD14; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; NF-KAPPA B; RECEPTORS, IGG; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UREMIA;

EID: 84859426417     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9374-9     Document Type: Article

References (28)

1. Navarro-González, J.F., and C. Mora-Fernández. 2008. The role of inflammatory cytokines in diabetic nephropathy. Journal of the American Society of Nephrologists 19(3): 433-442. (Pubitemid 351355386)
2. Ortiz-Muñoz, G., V. Lopez-Parra, O. Lopez-Franco, et al. 2010. Suppressors of cytokine signaling abrogate diabetic nephropathy. Journal of the American Society of Nephrologists 21: 763-772.
3. O'Connor, J.C., A. Satpathy, M.E. Hartman, et al. 2005. IL-βmediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. Journal of Immunology 174(8): 4991-4997.
4. Ko, G.J., Y.S. Kang, S.Y. Han, et al. 2008. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrology, Dialysis, Transplantation 23(9): 2750-2760.
5. Mora, C., and J.F. Navarro. 2006. Inflammation and diabetic nephropathy. Current Diabetes Reports 6(6): 463-468. (Pubitemid 44896406)
6. Navarro, J.F., and C. Mora. 2006. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. The Scientific World Journal 6: 908-917. (Pubitemid 44252722)
7. Tuttle, K.R. 2005. Linking metabolism and immunology: diabetic nephropathyis an inflammatory disease. Journal of the American Society of Nephrologists 16(6): 1537-1538. (Pubitemid 41716459)
8. Kikuchi, Y., T. Imakiire, M. Yamada, et al. 2005. Mizoribine reduces renal injury and macrophage infiltration in non-insulin dependent diabetic rats. Nephrology, Dialysis, Transplantation 20(8): 1573-1581. (Pubitemid 41418579)
9. Giulietti, A., E. van Etten, L. Overbergh, et al. 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile 1,25- dihydroxyvitamin D3 works as anti-inflammatory. Diabetes Research and Clinical Practice 77: 47-57. (Pubitemid 46590467)
10. Ruster, C., and G. Wolf. 2008. The role of chemokines and chemokine receptors in diabetic nephropathy. Frontiers of Bioscience 13: 944-955. (Pubitemid 351594739)
11. Chow, F., E.Ozols,D.J. Nikolic-Paterson, et al. 2004. Macrophages in mouse type 2 diabetic nephropathy: correlationwith diabetic state, and progressive renal injury. Kidney International 65: 116-128. (Pubitemid 38037496)
12. Furuta, T., T. Saito, T. Ootaka, et al. 1993. The role of macrophages in diabetic glomerulosclerosis. American Journal of Kidney Diseases 21: 480-485. (Pubitemid 23160508)
13. Utimura, R., C.K. Fujihara, A.L. Mattar, et al. 2003. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney International 63: 209-216. (Pubitemid 35463923)
14. ManLi, L., G. Hua, and Q. Lin. 2009. The expression of TLR4 on peripheral blood monocytes from uremic patients with diabetic nephropathy and its relation with plasma MCP-1 concentration. China Immunology Journal 25(9): 848-850.
15. Hypponen, E., B.J. Boucher, D.J. Berry, et al. 2008. 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross sectional study in the 1958 British Birth Cohort. Diabetes 57(2): 298-305.
16. Devaraj, S., J.-M. Yun, C.R. Duncan-Staley, et al. 2011. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. American Society for Clinical Pathology 135: 429-433.
17. Ozfirat, Z., and T.A. Chowdhury. 2010. Vitamin D deficiency and type 2 diabetes. Postgraduate Medical Journal 86: 18-25.
18. Kayaniyil, S., R. Vieth, R. Retnakaran, et al. 2010. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 33(6): 1379-1381.
19. Di Cesar, D.J., R. Ploutz-Snyder, R.S. Weinstock, et al. 2006. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 29(1): 174. (Pubitemid 44033461)
20. Du, T., Z.-G. Zhou, S. You, et al. 2009. Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM. Diabetes Research and Clinical Practice 83(2): 208-214.
21. Sadeghi, K., B. Wessner, U. Laggner, et al. 2006. Vitamin D3 down-regulates monocyte TLR expression and triggers hypores-ponsiveness to pathogen-associated molecular patterns. European Journal of Immunology 36: 361-370. (Pubitemid 43257459)
22. + blood monocytes: their role in infection and inflammation. Journal of Leukocyte Biology 81: 584-592.
23. Patino, R., J. Ibarra, A. Rodriguez, et al. 2000. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression. The American Journal of Cardiology 85: 1288-1291. (Pubitemid 30314658)
24. Ulrich, C., G.H. Heine, M.K. Gerhart, et al. 2008. Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. American Journal of Transplantation 8(1): 103-110.
25. Barisione, C., S. Garibaldi, G. Ghigliotti, et al. 2010. CD14CD16 monocyte subset levels in heart failure patients. Disease Markers 28(2): 115-124.
26. 4receptor, BLT1, in human monocytes. Journal of Leukocyte Biology 77: 1018-1025.
27. +monocytes and cardiovascular outcome in patients with chronic kidney disease. European Heart Journal 32(1): 84-92.
28. + T cell responses. Journal of Immunology 185: 2116-2124.